Treace Medical Concepts, Inc. Operating Income
Treace Medical Concepts, Inc. (TMCI) reported Operating Income of -$14.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-07
- Treace Medical Concepts, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$14.96M.
- Treace Medical Concepts, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$17.17M.
- Treace Medical Concepts, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$5.92M.
- Treace Medical Concepts, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$15.68M.
- Treace Medical Concepts, Inc. operating income (loss) for fiscal 2025 was -$54.15M.
- Treace Medical Concepts, Inc. operating income (loss) for fiscal 2024 was -$55.69M.
- Treace Medical Concepts, Inc. operating income (loss) for fiscal 2023 was -$51.43M.
- Treace Medical Concepts, Inc. operating income (loss) for fiscal 2022 was -$34.84M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$14.96M 10-Q · filed 2026-08-07 | -$32.13M 10-Q · filed 2026-08-07 | -$38.05M derived: sum of 3 quarters · filed 2026-08-07 | -$53.72M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$17.17M 10-Q · filed 2026-05-08 | -$23.09M derived: sum of 2 quarters · filed 2026-05-08 | -$38.77M derived: sum of 3 quarters · filed 2026-05-08 | -$55.74M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$21.60M derived: sum of 2 quarters · filed 2026-02-27 | -$38.57M derived: sum of 3 quarters · filed 2026-08-07 | -$54.15M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$15.68M 10-Q · filed 2025-11-06 | -$32.65M derived: sum of 2 quarters · filed 2026-08-07 | -$48.23M 10-Q · filed 2025-11-06 | -$48.44M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$16.97M 10-Q · filed 2026-08-07 | -$32.56M 10-Q · filed 2026-08-07 | -$32.76M derived: sum of 3 quarters · filed 2026-08-07 | -$47.89M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$15.58M 10-Q · filed 2026-05-08 | -$15.79M derived: sum of 2 quarters · filed 2026-05-08 | -$30.92M derived: sum of 3 quarters · filed 2026-05-08 | -$52.30M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$15.34M derived: sum of 2 quarters · filed 2026-02-27 | -$36.72M derived: sum of 3 quarters · filed 2026-02-27 | -$55.69M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$15.13M 10-Q · filed 2025-11-06 | -$36.52M derived: sum of 2 quarters · filed 2025-11-06 | -$55.48M 10-Q · filed 2025-11-06 | -$62.27M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$21.38M 10-Q · filed 2025-08-07 | -$40.35M 10-Q · filed 2025-08-07 | -$47.13M derived: sum of 3 quarters · filed 2026-02-27 | -$64.95M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$18.97M 10-Q · filed 2025-05-08 | -$25.75M derived: sum of 2 quarters · filed 2026-02-27 | -$43.57M derived: sum of 3 quarters · filed 2026-02-27 | -$56.62M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$6.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$24.60M derived: sum of 2 quarters · filed 2026-02-27 | -$37.65M derived: sum of 3 quarters · filed 2026-02-27 | -$51.43M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$17.82M 10-Q · filed 2024-11-05 | -$30.87M derived: sum of 2 quarters · filed 2024-11-05 | -$44.65M 10-Q · filed 2024-11-05 | -$48.14M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$13.05M 10-Q · filed 2024-08-06 | -$26.83M 10-Q · filed 2024-08-06 | -$30.32M derived: sum of 3 quarters · filed 2025-02-27 | -$41.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$13.78M 10-Q · filed 2024-05-07 | -$17.27M derived: sum of 2 quarters · filed 2025-02-27 | -$28.59M derived: sum of 3 quarters · filed 2025-02-27 | -$40.52M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$14.81M derived: sum of 2 quarters · filed 2025-02-27 | -$26.75M derived: sum of 3 quarters · filed 2025-02-27 | -$34.84M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$11.32M 10-Q · filed 2023-11-09 | -$23.25M derived: sum of 2 quarters · filed 2023-11-09 | -$31.35M 10-Q · filed 2023-11-09 | -$36.94M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$11.93M 10-Q · filed 2023-08-09 | -$20.03M 10-Q · filed 2023-08-09 | -$25.63M derived: sum of 3 quarters · filed 2024-02-27 | -$31.09M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$8.10M 10-Q · filed 2023-05-09 | -$13.69M derived: sum of 2 quarters · filed 2024-02-27 | -$19.15M derived: sum of 3 quarters · filed 2024-02-27 | -$23.20M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$11.06M derived: sum of 2 quarters · filed 2024-02-27 | -$15.11M derived: sum of 3 quarters · filed 2024-02-27 | -$16.51M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$5.46M 10-Q · filed 2022-11-09 | -$9.51M derived: sum of 2 quarters · filed 2022-11-09 | -$10.91M 10-Q · filed 2022-11-09 | -$7.28M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | -$4.05M 10-Q · filed 2022-08-10 | -$5.45M 10-Q · filed 2022-08-10 | -$1.82M derived: sum of 3 quarters · filed 2023-03-08 | -$1.88M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | -$1.40M 10-Q · filed 2022-05-06 | $2.23M derived: sum of 2 quarters · filed 2023-03-08 | $2.17M derived: sum of 3 quarters · filed 2023-03-08 | $652.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $3.57M derived: sum of 2 quarters · filed 2023-03-08 | $2.05M derived: sum of 3 quarters · filed 2023-03-08 | $855.00K 10-K · filed 2023-03-08 |
| 2020-09-30 | -$63.00K 10-Q · filed 2021-11-04 | -$1.58M derived: sum of 2 quarters · filed 2021-11-04 | -$2.78M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$1.52M 10-Q · filed 2021-08-05 | -$2.72M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$1.20M 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | -$3.54M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |